Comparison of Combination Plasmapheresis/IVIg/ Anti-CD20 Versus High-Dose IVIg in the Treatment of Antibody-Mediated Rejection
Under a Creative Commons license
open archive
Key words
Allograft survival
anti-CD20 monoclonal antibody
anti-HLA antibodies
antibody-mediated rejection
donor-specific antibodies
intravenous immunoglobulin
Cited by (0)
Copyright © 2009 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.